Alpha Healthcare III (ALPA) to Combine with Carmell Therapeutics in $188M Deal
Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) has entered into a definitive agreement to combine with drug developer Carmell at an enterprise value of $188.4 million. Pittsburgh-based Carmell is developing a treatment platform to accelerate healing in bone fractures and soft tissue wounds. The combined company is expected to trade on the Nasdaq under the symbolRead More